These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 38189130)
1. The complex heterogeneity of immune cell signatures across wasting tissues with C26 and 5-fluorouracil-induced cachexia. VanderVeen BN; Cardaci TD; Bullard BM; Huss AR; McDonald SJ; Muhammed AD; Kubinak JL; Fan D; Murphy EA Am J Physiol Cell Physiol; 2024 Feb; 326(2):C606-C621. PubMed ID: 38189130 [TBL] [Abstract][Full Text] [Related]
2. Quercetin Improved Muscle Mass and Mitochondrial Content in a Murine Model of Cancer and Chemotherapy-Induced Cachexia. VanderVeen BN; Cardaci TD; Cunningham P; McDonald SJ; Bullard BM; Fan D; Murphy EA; Velázquez KT Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615760 [TBL] [Abstract][Full Text] [Related]
3. Obesity reduced survival with 5-fluorouracil and did not protect against chemotherapy-induced cachexia or immune cell cytotoxicity in mice. VanderVeen BN; Cardaci TD; McDonald SJ; Madero SS; Unger CA; Bullard BM; Enos RT; Velázquez KT; Kubinak JL; Fan D; Murphy EA Cancer Biol Ther; 2022 Dec; 23(1):1-15. PubMed ID: 35968771 [TBL] [Abstract][Full Text] [Related]
5. The Acute Effects of 5 Fluorouracil on Skeletal Muscle Resident and Infiltrating Immune Cells in Mice. VanderVeen BN; Sougiannis AT; Velazquez KT; Carson JA; Fan D; Murphy EA Front Physiol; 2020; 11():593468. PubMed ID: 33364975 [TBL] [Abstract][Full Text] [Related]
6. Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism. Pin F; Barreto R; Couch ME; Bonetto A; O'Connell TM J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):140-154. PubMed ID: 30680954 [TBL] [Abstract][Full Text] [Related]
7. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model. Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652 [TBL] [Abstract][Full Text] [Related]
8. Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse. Aulino P; Berardi E; Cardillo VM; Rizzuto E; Perniconi B; Ramina C; Padula F; Spugnini EP; Baldi A; Faiola F; Adamo S; Coletti D BMC Cancer; 2010 Jul; 10():363. PubMed ID: 20615237 [TBL] [Abstract][Full Text] [Related]
9. Moderate exercise in mice improves cancer plus chemotherapy-induced muscle wasting and mitochondrial alterations. Ballarò R; Beltrà M; De Lucia S; Pin F; Ranjbar K; Hulmi JJ; Costelli P; Penna F FASEB J; 2019 Apr; 33(4):5482-5494. PubMed ID: 30653354 [TBL] [Abstract][Full Text] [Related]
10. Administration of adiponectin receptor agonist AdipoRon relieves cancer cachexia by mitigating inflammation in tumour-bearing mice. Massart IS; Kouakou AN; Pelet N; Lause P; Schakman O; Loumaye A; Abou-Samra M; Deldicque L; Bindels LB; Brichard SM; Thissen JP J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):919-933. PubMed ID: 38572511 [TBL] [Abstract][Full Text] [Related]
12. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice. Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531 [TBL] [Abstract][Full Text] [Related]
13. Myostatin is a novel tumoral factor that induces cancer cachexia. Lokireddy S; Wijesoma IW; Bonala S; Wei M; Sze SK; McFarlane C; Kambadur R; Sharma M Biochem J; 2012 Aug; 446(1):23-36. PubMed ID: 22621320 [TBL] [Abstract][Full Text] [Related]
14. Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia. Ham DJ; Murphy KT; Chee A; Lynch GS; Koopman R Clin Nutr; 2014 Jun; 33(3):448-58. PubMed ID: 23835111 [TBL] [Abstract][Full Text] [Related]
15. Voluntary exercise does not improve muscular properties or functional capacity during C26-induced cancer cachexia in mice. Hiroux C; Dalle S; Koppo K; Hespel P J Muscle Res Cell Motil; 2021 Jun; 42(2):169-181. PubMed ID: 33606189 [TBL] [Abstract][Full Text] [Related]
16. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia. Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162 [TBL] [Abstract][Full Text] [Related]
17. Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway. Shen Q; Kuang JX; Miao CX; Zhang WL; Li YW; Zhang XW; Liu X Phytomedicine; 2022 Jan; 95():153858. PubMed ID: 34861585 [TBL] [Abstract][Full Text] [Related]
18. Muscle and serum metabolomes are dysregulated in colon-26 tumor-bearing mice despite amelioration of cachexia with activin receptor type 2B ligand blockade. Lautaoja JH; Lalowski M; Nissinen TA; Hentilä J; Shi Y; Ritvos O; Cheng S; Hulmi JJ Am J Physiol Endocrinol Metab; 2019 May; 316(5):E852-E865. PubMed ID: 30860875 [TBL] [Abstract][Full Text] [Related]
19. Fuzheng Xiaoai Decoction 1 ameliorated cancer cachexia-induced muscle atrophy via Akt-mTOR pathway. Cheng QQ; Mao SL; Yang LN; Chen L; Zhu JZ; Liu X; Hou AJ; Zhang RR J Ethnopharmacol; 2023 Mar; 303():115944. PubMed ID: 36410574 [TBL] [Abstract][Full Text] [Related]
20. Paeoniflorin alleviated muscle atrophy in cancer cachexia through inhibiting TLR4/NF-κB signaling and activating AKT/mTOR signaling. Zhu Z; Li C; Gu X; Wang X; Zhang G; Fan M; Zhao Y; Liu X; Zhang X Toxicol Appl Pharmacol; 2024 Mar; 484():116846. PubMed ID: 38331105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]